* gender factor (male=1, female=0.85)

Similar documents
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16

OPAT discharge navigator and laboratory monitoring Select OPAT button for ALL patients that discharge on intravenous antimicrobials

Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

Effectiv. q3) Purpose of Policy. Pharmacy: Antimicrobial subcommp&tittee of

PIPERACILLIN- TAZOBACTAM INJECTION - SUPPLY PROBLEMS

Perichondritis: Source: UpToDate Ciprofloxacin 10 mg/kg/dose PO (max 500 mg/dose) BID Inpatient: Ceftazidime 50 mg/kg/dose q8 hours IV

Examples of Antimicrobial Stewardship Interventions: a couple of starter projects

Clinical Practice Standard

Measurement of Antimicrobial Drug Use. Elizabeth Dodds Ashley, PharmD, MHS, FCCP, BCPS DASON Liaison Pharmacist

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

Antibiotic Abyss. Discussion Points. MRSA Treatment Guidelines

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

PRACTIC GUIDELINES for APPROPRIATE ANTIBIOTICS USE

Antibiotic Updates: Part II

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Antimicrobial Susceptibility Testing: Advanced Course

Antimicrobial Stewardship 101

Provincial Drugs & Therapeutics Committee Memorandum Version 2

Health PEI: Provincial Antibiotic Advisory Team Empiric Antibiotic Treatment Guidelines for Sepsis Syndromes in Adults

CONTAGIOUS COMMENTS Department of Epidemiology

Stanford Antimicrobial Safety and Sustainability Program Antimicrobial Restriction Policy

Antimicrobial Stewardship Program

Stanford Antimicrobial Safety and Sustainability Program Antimicrobial Restriction Policy

Antibiotic Stewardship Program (ASP) CHRISTUS SETX

Adult Antimicrobial. Formulary Guide

These recommendations were approved for use by the Pharmaceutical and Therapeutics Committee, RCWMCH on 1 February 2017.

Measuring Antibiotic Use in NHSN

CONTAGIOUS COMMENTS Department of Epidemiology

Antimicrobial Therapy

Antibiotic Usage Guidelines in Hospital

The Inpatient Management of Febrile Neutropenia

Preserve the Power of Antibiotics

Consider the patient, the drug and the device how do you choose?

Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.

UCSF Medical Center Guidelines for Inpatient Management of Febrile Neutropenia

Antibiotic Updates: Part I

Central Nervous System Infections

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Discussion Points. Decisions in Selecting Antibiotics

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

Effective 9/25/2018. Contact for previous versions.

This survey was sent only to EIN members with a pediatric infectious diseases practice.

2015 Antibiotic Susceptibility Report

Bad Bugs. Pharmacist Learning Objectives. Antimicrobial Resistance. Patient Case. Pharmacy Technician Learning Objectives 4/8/2016

Antimicrobial Pharmacodynamics

General Approach to Infectious Diseases

Pharmacokinetic & Pharmadynamic of Once Daily Aminoglycosides (ODA) and their Monitoring. Janis Chan Pharmacist, UCH 2008

2016 Antibiotic Susceptibility Report

NHS Grampian Staff Policy For Optimising Use Of Alert (Restricted) Antimicrobials

Antimicrobial Susceptibility Testing: The Basics

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Appropriate antimicrobial therapy in HAP: What does this mean?

PRMCE ANTI-INFECTIVES SELECTION GUIDELINE FOR ADULTS (Revision October 22, 2015)

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

Introduction to Pharmacokinetics and Pharmacodynamics

10/13/14. Low: not well absorbed. Good: [blood and tissue] < than if given IV. High: > 90% absorption orally

Antimicrobial Stewardship Program: Local Experience

Misericordia Community Hospital (MCH) Antimicrobial Stewardship Report

Antimicrobial Stewardship Programs The Same, but Different. Sara Nausheen, MD Kevin Kern, PharmD

CF WELL Pharmacology: Microbiology & Antibiotics

Appropriate Management of Common Pediatric Infections. Blaise L. Congeni M.D. Akron Children s Hospital Division of Pediatric Infectious Diseases

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

Antimicrobial Susceptibility Patterns

Antimicrobial Stewardship: Stopping the Spread of Antibiotic Resistance

% Susceptible Atlanta VAMC January - December 2018

EUCAST recommended strains for internal quality control

Updates on the Management of Hospital Acquired Infections and Resistant Organisms

Updates on the Management of Hospital Acquired Infections and Resistant Organisms

4/3/2017 CLINICAL PEARLS: UPDATES IN THE MANAGEMENT OF NOSOCOMIAL PNEUMONIA DISCLOSURE LEARNING OBJECTIVES

INFECTIOUS DISEASE ANTIMICROBIAL REVIEW. Michelle Aguirre Janel Liane Cala PGY1 Pharmacy Practice Residents Medical Center Hospital

Appropriate Antimicrobial Therapy for Treatment of

National Antimicrobial Prescribing Survey

Antibiotic Stewardship at MetroWest Medical Center. Colleen Grocer, RPh, BCOP Co-Chair, Antibiotic Stewardship Committee

SHC Surgical Antimicrobial Prophylaxis Guidelines

1. List three activities pharmacists can implement to support. 2. Identify potential barriers to implementing antimicrobial

Developed by Kathy Wonderly RN, MSEd,CPHQ Developed: October 2009 Most recently updated: December 2014

Infectious Disease 101: Helping the Consultant Pharmacist with Stewardship Principles

SMART WORKFLOW SOLUTIONS Introducing DxM MicroScan WalkAway System* ...

INFECTIOUS DISEASES DIAGNOSTIC LABORATORY NEWSLETTER

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

OPTIMIZATION OF PK/PD OF ANTIBIOTICS FOR RESISTANT GRAM-NEGATIVE ORGANISMS

I am writing in response to your request for information made under the Freedom of Information Act 2000 in relation to Antibiotics.

Antibiotics: Selected Topics Steven Park, MD/PhD Director, Antimicrobial Stewardship Program Division of Infectious Diseases UCI Medical Center

St. Joseph s General Hospital Vegreville. and. Mary Immaculate Care Centre. Antimicrobial Stewardship Report

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship July December 2017

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

High Risk Emergency Medicine. Antibiotic Pitfalls

Septicaemia Definitions 1

Grey Nuns Community Hospital (GNCH) Antimicrobial Stewardship Report

Interactive session: adapting to antibiogram. Thong Phe Heng Vengchhun Felix Leclerc Erika Vlieghe

a. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.

AMR Industry Alliance Antibiotic Discharge Targets

Antimicrobial Stewardship Programs (ASPs) Metrics Examples

Updated recommended treatment regimens for gonococcal infections and associated conditions United States, April 2007

Guidelines for Treatment of Urinary Tract Infections

Concise Antibiogram Toolkit Background

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Antimicrobial Stewardship Program 2 nd Quarter

Optimize Durations of Antimicrobial Therapy

Transcription:

Usual Doses of Antimicrobials Typically Not Requiring Renal Adjustment Azithromycin 250 500 mg Q24 *Amphotericin B 1 3-5 mg/kg Q24 Clindamycin 600 900 mg Q8 Liposomal (Ambisome ) Doxycycline 100 mg Q12 *Micafungin 100 mg Q24 *Linezolid 600 mg Q12 150 mg Q24 for invasive Aspergillus Metronidazole 2 500 mg Q8-12 (Q8 for C.difficile) *Voriconazole 3 Based on indication. See Cerner CareSet. *Tigecycline 100 mg x 1 dose, then 50 mg Q12 (if Child-Pugh=C, adjust maintenance dose to 25 mg Q12) IV voriconazole not recommended if CrCL <50 ml/min due to accumulation and potential toxicity from SBECD vehicle. PO preferred. Exceptions exist. ANTIBACTERIALS *Amikacin 6 15 mg/kg Q24 5 mg/kg Q12 5 mg/kg Q24 5 mg/kg Q24-48 Ampicillin UTI, Mild infection 1 g Q6 1 g Q8 1 g Q8 1 g Q12 Moderate-Severe infection, Endocarditis, Meningitis 2 g Q4 2 g Q6 2 g Q6 2 g Q12 Ampicillin/Sulbactam 1.5-3 g Q6 1.5-3 g Q6 1.5-3 g Q12 1.5-3 g Q24 Aztreonam Mild-Moderate infection 1 g Q8 1 g Q8 1 g Q12 1 g Q24 Neutropenic fever, Severe infection 2 g Q8 2 g Q8 2 g Q12 2 g Q24 Cefazolin UTI, Mild SSTI 1 g Q8 1 g Q8 1 g Q12 500 mg Q24 All other indications 2 g Q8 2 g Q8 1 g Q12 1 g Q24 or 2 g TIW post-hd 1 Use total body weight. Round to nearest 50 mg. Routine monitoring of CMP and IV hydration pre- and post- recommended. 2 Some recommendations include metronidazole 500 mg Q12 in HD patients for prolonged durations >14 days 3 Use adjusted body weight if patient is > 120% ideal body weight 4 Usual dose recommended for patients with normal renal function 5 Administer post-hd if on Q24+ hour interval. 6 Use adjusted body weight if patient is > 120% ideal body weight. Round to nearest 50 mg. SHARP Antimicrobial Stewardship Program Last updated: Dec 2017 1

Cefepime Standard Dose 1 g Q8 1 g Q12 1 g Q24 500 mg Q24 Neutropenic fever, Meningitis, 1 g Q24 2 g Q8 1 g Q8 1 g Q12 CF, Pseudomonas or 2 g TIW post-hd Cefotetan 1-2 g Q12 1-2 g Q12 1-2 g Q24 500 mg Q24+500 mg post-hd Cefoxitin 1-2 g Q6 1-2 g Q8 1-2 g Q12 1 g Q24 *Ceftaroline Standard Dose 600 mg Q12 400 mg Q12 300 mg Q12 200 mg Q12 Endocarditis, S.aureus Bacteremia 600 mg Q8 400 mg Q8 300 mg Q8 200 mg Q8 Ceftazidime Pseudomonas 2 g Q8 2 g Q12 2 g Q24 1 g Q24 *Ceftazidime/Avibactam Restricted to ID only per P&T 2.5 g Q8 1.25 g Q8 0.94 g Q12 0.94 g Q24 *Ceftolozane/Tazobactam Restricted to ID only per P&T All other indications 1.5 g Q8 750 mg Q8 375 mg Q8 750 mg x 1 dose, then 150 mg Q8 Pneumonia 3 g Q8 1.5 g Q8 750 mg Q8 1.5 g x 1 dose, then 300 mg Q8 Cefuroxime IV Mild-moderate infection 750 mg Q8 750 mg Q8 750 mg Q12 750 mg Q24 Severe infection 1.5 g Q8 1.5 g Q8 1.5 g Q12 1.5 g Q24 Ciprofloxacin IV Standard dose 400 mg Q12 400 mg Q12 400 mg Q24 400 mg Q24 Pneumonia, Severe Infection 400 mg Q8 400 mg Q8 400 mg Q12 400 mg Q24 *Colistimethate sodium Please see Colistin IV Dosing Guideline Consult pharmacy Consult pharmacy Consult pharmacy Consult pharmacy SHARP Antimicrobial Stewardship Program Last updated: Dec 2017 2

*Dalbavancin Restricted to outpatient infusion Single-dose regimen 1.5 g x 1 dose 1.5 g x 1 dose 1.125 g x 1 dose 1.5 g x 1 dose Two-dose regimen (separated by 1 week) 750 mg x 1 dose, then 375 mg x 1 week later *Daptomycin 7 SSTI 4-6 mg/kg Q24 4-6 mg/kg Q24 4-6 mg/kg Q48 4-6 mg/kg Q48 Bacteremia 8, Systemic Infection 6-10 mg/kg Q24 6-10 mg/kg Q24 6-10 mg/kg Q48 6-10 mg/kg Q48 *Ertapenem 1 g Q24 1 g Q24 500 mg Q24 500 mg Q24 (post HD) Gentamicin 9 5 mg/kg Q24 1.5 2 mg/kg Q12 1.5 2 mg/kg Q24 1.5 2 mg/kg Q24-48 *Imipenem/Cilastatin 10 CrCL <10 ml/min Standard Dose 500 mg Q6 500 mg Q8 500 mg Q12 250-500 mg Q12 Must institute HD within 48 hrs Severe infections and MIC 2 CrCL 90: 1 g Q6 500 mg Q12 500 mg Q6 500 mg Q12 (NTE 50mg/kg/d or 4g/d) CrCL 89-50: 750 mg Q8 Must institute HD within 48 hrs Levofloxacin 9 CrCL 50 ml/min CrCL 49-20 ml/min CrCL 19-10 ml/min CrCL <10 ml/min, ihd, CAPD All other indications 750 mg Q24 750 mg Q48 750 mg x1, then 500 mg Q48 750 mg x1, then 500 mg Q48 Cystitis or weight <45 kg 500 mg Q24 500 mg Q48 500 mg x1, then 250 mg Q48 500 mg x1, then 250 mg Q48 *Meropenem ihd: 30-min infusion Standard dose (30min infusion) 500 mg Q6 500 mg Q8 500 mg Q12 500 mg Q24 Meningitis, Cystic Fibrosis 2 g Q8 2 g Q12 1 g Q12 1 g Q24 *Minocycline IV MDR Acinetobacter Infection 200 mg Q12 200 mg IV LOAD, then 100 mg Q12 Penicillin G IV 2-4 mu Q4 2-4 mu Q6 2-4 mu Q6 1-2 mu Q6 Piperacillin/Tazobactam 4-hr infusion: CrCL >20 ml/min 4-hr infusion CrCL 20 ml/min ihd: 30-min infusion 7 Use total body weight. Round to nearest 50 mg. Routine serum CK monitoring recommended for prolonged use. 8 Experts recommend 8-10 mg/kg once daily for complicated bacteremia or infective endocarditis. 9 Use adjusted body weight if patient is > 120% ideal body weight. Round to nearest 20 mg. 10 Note differences in renal function (CrCL) ranges. SHARP Antimicrobial Stewardship Program Last updated: Dec 2017 3

Standard dose 3.375 4.5 g Q8 3.375 4.5 g Q8 3.375 4.5 g Q12 ihd: 2.25 g Q8 Weight >100 kg or Sepsis 4.5 g Q8 4.5 g Q8 4.5 g Q12 ihd: 2.25 g Q8 Tobramycin 8 5 mg/kg Q24 1.5 2 mg/kg Q12 1.5 2 mg/kg Q24 1.5 2 mg/kg Q24-48 TMP/SMX (Bactrim/Septra) 11 UTI Equivalent to 1 DS tab BID Equiv to 1 DS tab BID Equivalent to 1 DS tab Daily Equiv to 1 DS tab Daily SSTI or Systemic GNR 5 mg/kg of TMP Q12 5 mg/kg of TMP Q12 2.5 mg/kg of TMP Q12 2.5 mg/kg of TMP Q24 Severe Infections, PCP 5 mg/kg of TMP Q6-8 5 mg/kg of TMP Q6-8 5 mg/kg of TMP Q12 5 mg/kg of TMP Q24 Vancomycin 12 15-20 mg/kg Q8-12 15-20 mg/kg Q12 15-20 mg/kg Q24 15-20 mg/kg Q24-48 ANTIFUNGALS Fluconazole Candidal UTI 200 mg Q24 100 mg Q24 100 mg Q24 100 mg Q24 Systemic Infection 13 400 mg Q24 200 mg Q24 200 mg Q24 200 mg Q24 Meningitis 800-1200 mg Q24 400-600 mg Q24 400-600 mg Q24 400-600 mg Q24 Note different renal function ranges for antivirals compared to above. ANTIVIRALS 9 CrCL 50 ml/min 4 CrCL 49-26 ml/min CrCL 25-10 ml/min CrCL <10 ml/min or ihd 5 Acyclovir 14 Genital HSV 5 mg/kg Q8 5 mg/kg Q12 5 mg/kg Q24 2.5 mg/kg Q24 HSV CNS Disease, VZV, Shingles 10 mg/kg Q8 10 mg/kg Q12 10 mg/kg Q24 5 mg/kg Q24 CrCL 50 ml/min 4 CrCL 49-26 ml/min CrCL 25-10 ml/min CrCL <10 ml/min or ihd 5 11 Use adjusted body weight if patient is > 120% ideal body weight. 12 Use total body weight, not to exceed 2 g/dose. Round to nearest 250 mg. 13 IDSA recommends 800 mg (~12 mg/kg) loading dose for candidemia / invasive candidiasis. Inadequate loading dose has been associated with mortality in those patients. 14 Use ideal body weight. Use adjusted body weight if patient is > 120% ideal body weight or life-threatening illness. Round to the nearest 50 mg. SHARP Antimicrobial Stewardship Program Last updated: Dec 2017 4

Cidofovir 15 Foscarnet Ganciclovir IV 16 CMV Induction or Prophylaxis Maintenance 5 mg/kg Q1-2 weeks Pre-existing renal impairment: Contraindicated for Scr >1.5 mg/dl, CrCL <55 ml/min, or urine protein 100 mg/dl ( 2+) If SCr by 0.3-0.4 mg/dl or >30% of baseline, reduce cidofovir dose to 3 mg/kg; discontinue therapy if SCr 0.5 mg/dl or development of 3+ proteinuria Use not recommended Varies based on indication, renal function, etc. Recommended consult to pharmacy Consult pharmacy Consult pharmacy Consult pharmacy Consult pharmacy CrCL 70: 5 mg/kg Q12 CrCL 50-69: 2.5 mg/kg Q12 2.5 mg/kg Q24 1.25 mg/kg Q24 CrCL 70: 5 mg/kg Q24 CrCL 50-69: 2.5 mg/kg Q24 1.25 mg/kg Q24 0.625 mg/kg Q24 1.25 mg/kg Q48 or TIW post-hd 0.625 mg/kg Q48 or TIW post-hd *Peramivir Note different renal function ranges. Restricted to ID or ICU. Courses >5 days restricted to ID Single dose 600 mg x 1 dose 200 mg x 1 dose 100 mg x 1 dose 100 mg x 1 dose post HD Daily regimen 600 mg Q24 200 mg Q24 100 mg Q24 CrCL <10 ml/min: 100 mg on day 1, then 15 mg Q24 HD: 100 mg on day 1, then 100 mg 2hrs post each HD session 15 Use total body weight. Consult ID or ID pharm for alternative dosing regimens. Pre-med: IV hydration, probenecid. 16 Use total body weight SHARP Antimicrobial Stewardship Program Last updated: Dec 2017 5